- Home
- DNTH vs FTDR Comparison
DNTH vs FTDR Comparison
Compare DNTH & FTDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNTH | FTDR |
|---|---|---|
| Founded | 2015 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.8B |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DNTH | FTDR |
|---|---|---|
| Price | $106.95 | $81.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $121.00 | $67.20 |
| AVG Volume (30 Days) | ★ 544.6K | 393.8K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 13.62 |
| EPS | N/A | ★ 2.33 |
| Revenue | $2,036,000.00 | ★ $2,093,000,000.00 |
| Revenue This Year | N/A | $5.97 |
| Revenue Next Year | $29.48 | $5.82 |
| P/E Ratio | ★ N/A | $34.52 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $32.28 | $48.47 |
| 52 Week High | $117.88 | $93.43 |
Technical Indicators
Market Signals| Indicator | DNTH | FTDR |
|---|---|---|
| Relative Strength Index (RSI) | 44.50 | 46.91 |
| Support Level | $101.19 | $78.47 |
| Resistance Level | $107.99 | $80.73 |
| Average True Range (ATR) | 4.59 | 1.85 |
| MACD | -0.85 | -0.60 |
| Stochastic Oscillator | 26.26 | 26.26 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
About FTDR Frontdoor Inc.
Frontdoor Inc is a United States-based company that provides home service plans. It owns multiple home service brands including American Home Shield, HSA, OneGuard, and Landmark brands. Through its home service plans, the company helps its customers maintain their homes and protect against costly and unexpected breakdowns of essential home systems and appliances.